ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 128 filers reported holding ANIKA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,090,225 | +120101.2% | 58,525 | +167114.3% | 0.00% | – |
| Q2 2023 | $907 | -56.7% | 35 | -52.1% | 0.00% | – |
| Q1 2023 | $2,095 | +4.8% | 73 | +2.8% | 0.00% | – |
| Q4 2022 | $2,000 | -98.9% | 71 | -99.1% | 0.00% | – |
| Q3 2022 | $180,000 | +39.5% | 7,553 | +30.5% | 0.00% | – |
| Q2 2022 | $129,000 | +163.3% | 5,786 | +195.5% | 0.00% | – |
| Q1 2022 | $49,000 | -23.4% | 1,958 | +8.2% | 0.00% | – |
| Q4 2021 | $64,000 | -7.2% | 1,810 | +9.6% | 0.00% | – |
| Q3 2021 | $69,000 | +165.4% | 1,652 | +169.1% | 0.00% | – |
| Q2 2021 | $26,000 | +2500.0% | 614 | +1515.8% | 0.00% | – |
| Q1 2021 | $1,000 | -98.6% | 38 | -97.5% | 0.00% | – |
| Q4 2020 | $69,000 | +430.8% | 1,550 | +318.9% | 0.00% | – |
| Q3 2020 | $13,000 | 0.0% | 370 | +3.9% | 0.00% | – |
| Q2 2020 | $13,000 | -13.3% | 356 | -26.7% | 0.00% | – |
| Q1 2020 | $15,000 | – | 486 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 591,675 | $17,513,580 | 14.58% |
| Trigran Investments, Inc. | 1,564,541 | $46,310,413 | 4.64% |
| DIKER MANAGEMENT LLC | 22,458 | $664,757 | 0.77% |
| Virtus Fund Advisers, LLC | 3,490 | $103,304 | 0.74% |
| Portolan Capital Management | 207,900 | $6,153,840 | 0.61% |
| Virtus Investment Advisers, Inc. | 16,086 | $476,146 | 0.32% |
| Ranger Investment Management | 140,205 | $4,150,068 | 0.31% |
| BOOTHBAY FUND MANAGEMENT, LLC | 367,510 | $10,878,296 | 0.25% |
| Riverwater Partners LLC | 9,778 | $289,429 | 0.25% |
| Legato Capital Management LLC | 7,556 | $223,658 | 0.04% |